Summary:
Evaluating the Safety and Immune Response to different doses of the CMV Vaccine in Healthy Patients
Criteria:Healthy Patients 18 - 50 yrs old
Be capable of giving signed informed consent
Participants who are willing and able to comply with all scheduled visits,vaccination plan, laboratory test, blood draws, and able to receive vaccine injections, and other study procedures, lifestyle consideration,
Qualified Participants May Receive:
1 Screening Visit
11 In-Clinic Follow-up Safety Check up's
7 Phone Call Visits
Participants will be compensated each completed visit.
Total compensated for completing the trial is $ 3,525